Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesAssociation of XPD Polymorphisms with Severe Toxicity in Non–Small Cell Lung Cancer Patients in a Chinese Population
Clinical Cancer Research, 06/03/09
Wu W et al. - This investigation, for the first time, provides suggestive evidence of an effect of XPD p.Arg156Arg polymorphism on severe toxicity variability among platinum-treated non–small cell lung cancer patients.
Related Articles
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 73%%
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Relevance Score: 72%%
Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Cancer Research, 10/06/09
Relevance Score: 71%%
Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
British Journal of Cancer, 11/30/09
Relevance Score: 70%%
African American lung cancer patients may have different response to new cancer-fighting drugs
EurekAlert, 10/08/09
Relevance Score: 70%%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
HMGB1-Mediated MMP-9 Expression in Non-Small Cell Lung Cancer Contributes to Tumor Cell Invasiveness
American Journal of Respiratory Cell and Molecular Biology, 11/30/09
Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene
Annals of Surgical Oncology, 11/25/09
Down-regulation of GRP78 Enhances Chemotherapy Sensitivity to VP-16 in Lung Adenocarcinoma
Chinese Journal of Lung Cancer, 11/25/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiproliferative effect of exemestane in lung cancer cells
Molecular Cancer, 11/30/09
Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: Updated survival analysis of JRB-10
Journal of Clinical Oncology, 11/30/09
Skeletal morbidity in lung cancer patients with bone metastases: Demonstrating the need for early diagnosis and treatment with bisphosphonates
Lung Cancer, 11/30/09
Sponsor
Article Search
Sponsor